子宫内膜异位症患者与男性低生育力夫妇移植同等质量胚胎后的着床受损比较:一项匹配队列研究
在比利时根特大学医院2015年7月至2017年8月间1053个IVF/ICSI新鲜单胚胎移植周期中,将118例子宫内膜异位症患者与118例男性低生育力夫妇按胚胎质量、女性年龄和产次1:1匹配。对照组第16天HCG阳性率、持续着床率、持续妊娠率和活产率均显著高于子宫内膜异位症组。
要点
- 匹配胚胎质量、女性年龄和产次后,男性低生育力对照组第16天HCG阳性率显著高于子宫内膜异位症组(P=0.047)。
- 对照组持续着床率(P=0.038)、持续妊娠率(P=0.046)和活产率(P=0.043)均显著高于子宫内膜异位症组。
- 对照组HCG阳性、持续着床、持续妊娠和活产的比值比均大于2。
核心结论
- 匹配胚胎质量、女性年龄和产次后,对照组第16天HCG阳性率、持续着床率、持续妊娠率和活产率均超过子宫内膜异位症组的两倍。
研究设计与样本
- 回顾性匹配队列研究,纳入比利时根特大学医院辅助生殖医学科2015年7月至2017年8月间1053个IVF/ICSI新鲜单胚胎移植周期。
- 118例子宫内膜异位症病例与118例男性低生育力夫妇按胚胎质量(相同ALPHA分级类别)、女性年龄(±1岁)和产次(±1次分娩)1:1匹配。
- 子宫内膜异位症通过经阴道超声、磁共振成像或腹腔镜诊断,并按修订版美国生殖医学学会评分分为I/II级与III/IV级。
- 男性低生育力按世界卫生组织标准(第五版)定义。
主要发现
- 对照组第16天HCG阳性率显著高于子宫内膜异位症组(P=0.047,OR 2.077,CI 1.009至4.276)。
- 对照组持续着床率(定义为妊娠至少6.5-7周时经阴道超声见胎心阳性)显著高于子宫内膜异位症组(P=0.038,OR 2.265,CI 1.048至4.893)。
- 对照组持续妊娠率(定义为11周时活胎妊娠)显著高于子宫内膜异位症组(P=0.046,OR 2.292,CI 1.016至5.173)。
- 对照组活产率显著高于子宫内膜异位症组(P=0.043,OR 2.502,CI 1.029至6.087)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Is implantation impaired in patients with endometriosis undergoing IVF and intracytoplasmatic sperm injection (ICSI) cycles? DESIGN: A retrospective matched cohort study was carried out on IVF/ICSI cycles with fresh single embryo transfer at the Department of Assisted Reproductive Medicine, Ghent University Hospital, Belgium, between July 2015 and August 2017 (n = 1053). A total of 118 endometriosis cases were matched 1:1 to 118 couples diagnosed with male subfertility and stratified by embryo quality (identical ALPHA grading categories), female age (±1 year) and parity (±1 delivery). Transvaginal ultrasound, magnetic resonance imaging or laparoscopy was used to diagnosed endometriosis, and the revised American Society for Reproductive Medicine score was used to classify the endometriosis into grade I/II versus grade III/IV. Male subfertility was defined in accordance with World Health Organization criteria (fifth edition). RESULTS: Compared with endometriosis cases, control couples with male subfertility had significantly higher rates of positive HCG test on day 16 (P = 0.047, OR 2.077, CI 1.009 to 4.276), ongoing implantation (defined as a positive fetal heart rate on transvaginal ultrasound at a gestational age of at least 6.5-7 weeks) (P = 0.038, OR 2.265, CI 1.048 to 4.893), ongoing pregnancy (defined by a vital pregnancy at 11 weeks) (P = 0.046, OR 2.292, CI 1.016 to 5.173) and live birth (P = 0.043, OR 2.502, CI 1.029 to 6.087). CONCLUSIONS: After matching for embryo quality, woman's age and parity, rates of positive HCG tests, ongoing implantation, ongoing pregnancy and live birth were more than twice as high in the control group compared with the endometriosis group.
引用
- Blank C, Deboever C, Decroos E, et al. Impaired implantation in endometriosis compared with couples with male subfertility after transfer of equal quality embryos: a matched cohort study. Reprod Biomed Online. 2020. PMID: 34756367. doi:10.1016/j.rbmo.2020.08.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。